Magnetic nanoparticles and rapamycin encapsulated into polymeric nanocarriers

Area of Science:

• Biomaterials Science
• Nanotechnology
• Pharmaceutical Sciences

Background:

• Polymeric nanoparticles offer versatile platforms for drug delivery.
• Magnetic nanoparticles enable targeted delivery through external magnetic fields.
• Rapamycin is an important immunosuppressant and anti-cancer drug.

Purpose of the Study:

• To develop polylactide-co-glycolide (PLGA) nanocapsules and nanospheres.
• To incorporate magnetic nanoparticles (MP) and rapamycin into these nanocarriers.
• To characterize the morphology, size, entrapment efficiency, stability, and magnetic properties.

Main Methods:

• Magnetic nanoparticles synthesized via co-precipitation.
• Nanocapsules (NC) and nanospheres (NS) prepared using emulsion evaporation.
• MP coated with oleic acid (MPOA, MPOA-OA) or uncoated were used.
• Rapamycin encapsulation and characterization of physical and magnetic properties.

Main Results:

• Composite nanoparticles were spherical with a mean diameter of ~120 nm and narrow size distribution.
• NC and NS with uncoated MP showed higher entrapment efficiency and stability.
• Superparamagnetic behavior was confirmed, indicating potential for magnetic targeting.
• PLGA nanocarriers demonstrated suitability for controlled drug release applications.

Conclusions:

• Developed PLGA nanocarriers effectively encapsulate magnetic nanoparticles and rapamycin.
• Uncoated magnetic nanoparticles enhance drug loading and stability in nanocarriers.
• The superparamagnetic properties suggest potential for magnetically guided drug delivery systems.
• These magnetic polymeric nanocarriers show promise for advanced controlled release drug targeting devices.